Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Psychiatric disorders are equally common during pregnancy as among non-pregnant women, and many of these conditions are treated with psychotropic medicines. Relatively little is known about patterns of use of many these agents during pregnancy, and specifically of how rates may have shifted during the last decade. We aimed to quantify the rate of pregnancy related exposures to categories of psychotropic medicines stratified according to the primary indication for use (antidepressants, antipsychotics, anxiolytics, and psychostimulants), trimester of pregnancy, trends over time and region, and indication for use. METHODS: We conducted a retrospective cohort study of pregnancies among women in the Truven Health MarketScan database (source population 70 million Americans), which captures person-specific clinical use and includes detailed information on filled prescriptions, hospitalizations and outpatient visits for all privately insured employees and their dependents. We classified psychotropic medicines of interest using ATC level 3 accordingly: antipsychotics (N05A); anxiolytics (N05B); antidepressants (N06A); psychostimulants, agents used for ADHD and cognitive enhancement (N06B). We also examined temporal and regional trends in use. RESULTS: We included 343,299 women who had a live birth between Jan 1, 2006 and Dec 31, 2011, of whom 10.3% were dispensed one or more psychotropic medicines during pregnancy. This rate varied from 6% to 15% between states. The rate of use of psychotropic medicines was relatively stable between 2006 and 2011. The most commonly used psychotropic medicines were selective serotonin reuptake inhibitors (5.1%) and benzodiazepine or benzodiazepine-like medicines (3.9%). Among psychotropic users, the most commonly associated psychiatric diagnosis was depression (25.0%), followed by anxiety disorders (24.4%). Approximately 1.6% of women used more than one category of psychotropic medicine in pregnancy, most commonly an antidepressant and an anxiolytic medicine (1.2%). CONCLUSIONS: Given this relatively high rate of use, the lack of evidence that the most frequently used medications improve birth outcomes and the safety concerns associated with both early and late pregnancy use for many frequently-used medications, there is a need for further study of factors driving psychotropic medication use during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“ADHD is increasingly being diagnosed among adults as well as children [13].”
BackgroundGrote, N. K., Bridge, J. A., Gavin, A. R., Melville, J. L., Iyengar, S., & Katon, W. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.111 · Cited by 1,882 · cited 2×
“have worse birth outcomes, on average, than women without a psychiatric diagnosis, and this is often used as a rationale to support drug treatment in pregnancy [19].”
BackgroundMethodGaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
Psychiatric Disorders in Pregnant and Postpartum Women in the United States
Vesga-López, O., Blanco, C., Keyes, K., Olfson, M., Grant, B. F., & Hasin, D. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.805 · Cited by 1,065 · cited 1×
“Neither appears to be the case, with the most reliable estimates suggesting no significant difference in the rates of the most commonly diagnosed psychiatric disorders between pregnant and non-pregnant women of childbearing age, after adjustment for ethnicity, social class, age, health status and stressful life events…”
BackgroundAlder, J., Fink, N., Bitzer, J., Hösli, I., & Holzgreve, W. (2007) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701209560 · Cited by 872 · cited 1×
“However, the evidence on depression and pregnancy outcomes has been criticized for inadequately addressing confounding [20], including socio-economic factors [19,21], psychiatric diagnoses [22] and pregnancy complications [23,24], and it is often unclear whether depression and anxiety diagnoses precede or follow pregn…”
BackgroundEffects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant
Iqbal, M. M., Sobhan, T., & Ryals, T. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.1.39 · Cited by 427 · cited 1×
“More importantly, to date there is no evidence that antidepressants for depression or anxiolytics for anxiety mitigate poorer health outcomes among women with depression or anxiety-related diagnoses [26-28].”
BackgroundRoss, L. E., Grigoriadis, S., Mamisashvili, L., VonderPorten, E. H., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.684 · Cited by 268
Petersen, I., Gilbert, R. E., Evans, S. J. W., Man, S.-L., & Nazareth, I. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06090blu · Cited by 192 · cited 1×
“Rates of use have also changed considerably over time [8-10].”
BackgroundAnxiety and depression in women and men from early pregnancy to 3-months postpartum
Figueiredo, B., & Conde, A. (2011) · Archives of Women's Mental Health · doi:10.1007/s00737-011-0217-3 · Cited by 191
National trends in antidepressant medication treatment among publicly insured pregnant women
Huybrechts, K. F., Palmsten, K., Mogun, H., Kowal, M., Avorn, J., Setoguchi-Iwata, S., & Hernández-Díaz, S. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.12.010 · Cited by 161 · cited 3×
“They also found that antidepressant use declined following an FDA warning in 2003 on increased risk for suicidality in children and adolescents [18].”
BackgroundInfluential
Research works printed but not linked: 37
- Cooper WO, Willy ME, Pont SJ, Ray WA: Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol. 2007, 196 (6): 544e1-544e5. · DOI · Paper page
- Muzik M, Marcus SM, Heringhausen JE, Flynn H: When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care. Obstet Gynecol Clin North Am. 2009, 36 (4): 771-788. · DOI · Paper page
- Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T: Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005, 106 (5): 1071-1083. · DOI · Paper page
- Gaynes BN, Gavin N, Meltzer-Brody S, Lohr KN, Swinson T, Gartlehner G, Brody S, Miller WC: Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes: Summary. 2005
- Oyebode F, Rastogi A, Berrisford G, Coccia F: Psychotropics in pregnancy: safety and other considerations. Pharmacol Ther. 2012, 135 (1): 71-77. · DOI
- Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Norgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B: Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. 2012, 344: d8012- · DOI · Paper page
- Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C: Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry. 2006, 63 (8): 898-906. · DOI · Paper page
- Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG: Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001–2006). Clin Ther. 2011, 34 (1): 239-249. · DOI
- Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS: Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Safety. 2011, 20 (2): 177-184. · DOI · Paper page
- McKenna K, Einarson A, Levinson A, Koren G: Significant changes in antipsychotic drug use during pregnancy. Vet Hum Toxicol. 2004, 46 (1): 44-46.
- Grigoriadis S, De CM, Barrons E, Bradley L, Eady A, Fishell A, Mamisachvili L, Cook GS, O'Keefe M, Romans S, Ross LE: Mood and anxiety disorders in a sample of Canadian perinatal women referred for psychiatric care. Arch Women's Mental Health. 2011, 14 (4): 325-333. · DOI
- Swanson LM, Pickett SM, Flynn H, Armitage R: Relationships among depression, anxiety, and insomnia symptoms in perinatal women seeking mental health treatment. J Women's Health. 2011, 20 (4): 553-558. · DOI · Paper page
- Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Dashevsky I, Haffenreffer K, Johnson KE, Toh S: Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013, 22 (5): 524-532. · DOI · Paper page
- Hoffman S, Hatch MC: Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol. 2000, 19 (6): 535-543. · doi:10.1037/0278-6133.19.6.535 · Paper page
- Steer RA, Scholl TO, Hediger ML, Fischer RL: Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992, 45 (10): 1093-1099. · DOI · Paper page
- Kozhimannil KB, Pereira MA, Harlow BL: Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009, 301 (8): 842-847. · DOI · Paper page
- Haelterman E, Breart G, Paris-Liado J, Dramaix M, Tchobroutsky C: Effect of uncomplicated chronic hypertension on the risk of small-for-gestational age birth. Am J Epidemiol. 1997, 145 (8): 689-695. · DOI
- Dayan J, Creveuil C, Herlicoviez M, Herbel C, Baranger E, Savoye C, Thouin A: Role of anxiety and depression in the onset of spontaneous preterm labor. Am J Epidemiol. 2002, 155 (4): 293-301. · DOI · Paper page
- Mintzes B, Wright JM: Are antidepressants safe in pregnancy? A focus on SSRIs. Therapeut Lett. 2010, 76: 1-2.
- Mintzes B, Fortin PM, Wright JM: Antidépresseurs et grossesse: Les inhibiteurs spécifiques de la recapture de la sérotonine. Médecine. 2010, 6 (6): 255-257.
- Eberhard-Gran M, Eskild A, Opjordsmoen S: Treating mood disorders during pregnancy: safety considerations. Drug Saf. 2005, 28 (8): 695-706. · DOI
- Nakhai-Pour HR, Broy P, Berard A: Use of antidepressants during pregnancy and the risk of spontaneous abortion. Can Med Assoc J. 2010, 182 (10): 1031-1037. · DOI · Paper page
- Huybrechts KF, Sanghani RS, Avorn J, Urato AC: Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis. PLoS ONE. 2014, 9 (3): e92778- · DOI · Paper page
- Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH: Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ. 2009, 339: b3569-b3575. · DOI · Paper page
- Jong GW, Einarson T, Koren G, Einarson A: Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): A systematic review. Reprod Toxicol. 2012, 34 (3): 293-297. · DOI
- Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL: Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996, 335 (14): 1010-1015. · DOI · Paper page
- Costei AM, Kozer E, Ho T, Ito S, Koren G: Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002, 156 (11): 1129-1132. · DOI · Paper page
- Laine K, Heikkinen T, Ekblad U, Kero P: Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003, 60 (7): 720-726. · DOI · Paper page
- Kallen B: Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004, 158 (4): 312-316. · DOI · Paper page
- Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W: Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry. 2004, 65 (2): 230-237. · DOI · Paper page
- McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J: Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs. 2010, 17 (2): 97-104. · DOI
- Hudak ML, Tan RC, Committee On DRUGS, Committee on Fetus and NEWBORN, American Academy of P: Neonatal Drug Withdrawal. Pediatrics. 2012, 129 (2): e540-e560. · DOI · Paper page
- Wang LH, Lin HC, Lin CC, Chen YH, Lin HC: Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clin Pharmacol Ther. 2010, 88 (3): 369-374. · DOI · Paper page
- Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, McKnight-Eily LR, Harrison L, D'Angelo DV, Williams L, Morrow B, Gould D, Safran MA, Centers for Disease Control and Prevention (CDC): Mental illness surveillance among adults in the United States. Morb Mortal Wkly Rep Surveill Summ. 2011, 60 (Suppl 3): 1-29.
- Markus AR, Rosenbaum S: The role of Medicaid in promoting access to high-quality, high-value maternity care. Womens Health Issues. 2010, 20 (1 Suppl): S67-S78. · doi:10.1016/j.whi.2009.11.012
- Bateman BT, Hernandez-Diaz S, Rathmell JP, Seeger JD, Doherty M, Fischer MA, Huybrechts KF: Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology. 2014, In press
- Mojtabai R, Olfson M: Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood). 2011, 30 (8): 1434-1442. · DOI · Paper page
Cited by
Ailes, E. C., Simeone, R. M., Dawson, A. L., Petersen, E. E., & Gilboa, S. M. (2016) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23573 · Cited by 112
Creeley, C. E., & Denton, L. K. (2019) · Brain Sciences · doi:10.3390/brainsci9090235 · Cited by 78
Freeman, M. P., Góez-Mogollón, L., McInerney, K. A., Davies, A. C., Church, T. R., Sosinsky, A. Z., Noe, O. B., Viguera, A. C., & Cohen, L. S. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2018.05.010 · Cited by 44
Bais, B., Kamperman, A. M., Bijma, H. H., Hoogendijk, W. J., Souman, J. L., Knijff, E., & Lambregtse-van den Berg, M. P. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038030 · Cited by 24
Metadata
- Authors
- Hanley, G. E., & Mintzes, B.
- Venue
- BMC Pregnancy and Childbirth
- Published
- 2014-07-22
- Volume
- 14
- Issue
- 1
- Pages
- 242-242
- ISSN
- 1471-2393 (ISSN-L)
- OpenAlex
- W2094051697
- Cited by
- 148
- References
- 12
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. https://app.cochat.ai/papers/10.1186/1471-2393-14-242
- The paper
- Hanley, G. E., & Mintzes, B. (2014). Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy and Childbirth. https://doi.org/10.1186/1471-2393-14-242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.